医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Tiens Group Held an International Health Industry Forum

2021年08月04日 PM04:28
このエントリーをはてなブックマークに追加


 

TIANJIN, China

As one of the most influential multinational enterprises in China, Tiens Group has been adhering to the development goal of helping people living better since 1995 until now. At the very beginning, the main products of Tiens Group included such healthy products as calcium products. But it has so far developed diversified industries concerning many fields such as cross-border e-commerce, international tourism, live broadcast and terminal experience stores, and has served more than 47 million families worldwide through its 110 branches around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210804005439/en/

(Photo: Business Wire)

(Photo: Business Wire)

An international health industry development forum will be organized by Tiens Group on August 3, 2021 (China time) to discuss about the development of the global health industry. Due to the great influence of Tiens Group worldwide, this forum has received a lot of media attention around the world. Li Jinyuan, Chairman of Tiens Group, said that the Group would make continuous efforts for “community of human health” as a major participant in the global massive health industry.

In 2013, China proposed the Belt and Road Initiative to strengthen the scale of transcontinental foreign trade cooperation. The Belt and Road Initiative has created many opportunities to promoted the trade in many countries and also reduced transportation and trade costs for specific countries. One of the important roles that Tiens Group plays in the construction of the Belt and Road is to promote the economic and trade cooperation and development between Tiens Group and the countries along the Belt and Road.

Considering the role of economic and trade cooperation as important pillar for many economies, Li Jinyuan, Chairman of Tiens Group started the direct selling business in 1995 and began to develop overseas business in 1997. What is worth mentioning is that its fledgling cross-border e-commerce business has been developing rapidly with the market developed in Europe, Aurasia, Asia Pacific, Africa, America and the Middle East, and its business scope covering 224 countries and regions in 224 countries. Three major overseas warehouses including European Czech warehouse, European Asian warehouse and African warehouse have been launched recently to ensure the support of global supply chain.

Thanks to persistent hard work over the past 26 years, Tiens Group has shifted from single product to diversified product structure, integrated health services and then multi-industry innovative and integrated development to establish a global network covering all countries. It has adopted innovative new models and mechanisms to help families create wealth through consumption, promote employment and entrepreneurship, help run global business and also enhance development.

It is reported that many members of “the Belt and Road” around the world has been interviewed in China and received positive reviews. Since its establishment, Tiens Group has been actively advocating, exploring and implementing new business models and concepts to create a global business system. As the practitioner of “the Belt and Road”, it has developed into a Chinese national brand which will eventually grow up to a global brand to promote broader global economic development.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210804005439/en/

CONTACT

Company: TIENS

Contact Person:Yukai Wang

Email:zcfw@tiens.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • DKT International Implements Traditional and New Forms of Marketing in Africa, South America, and Southeast Asia to Expand Access to Contraceptives
  • オルガノンが計画外妊娠をめぐり世界規模の対話の喚起を目指す
  • IHMA Opens Microbiology Reference Laboratory in Shanghai, China to Further Support Global Anti-Infective Product Discovery and Development
  • Cyclica and IMPACT Therapeutics Team Up to Advance Differentiated Anti-cancer Drug Development
  • Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries